Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 03, 2017 Filed Feb 8, 2017 23:31 UTC |
Stromatt Scott CChief Medical Officer and SVP
|
Exercise / conversionRestricted Stock Unit · Derivative | 27,381 | $0.00 | $0.00 |
DisclosureSEC source: 0001019056-17-000113 · stromatt_4.xml · derivative · entry 2 Stromatt Scott C · CIK 0001679975 · Chief Medical Officer and SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,941 Underlying: Common Stock · 27,381 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU converts into the Issuer's common stock on a one-for-one basis. F2 · derivative.exercise_date: On August 3, 2016, the reporting person was granted 54,762 RSUs, vesting in two equal installments on February 3, 2017 and February 3, 2018. F2 · derivative.expiration_date: On August 3, 2016, the reporting person was granted 54,762 RSUs, vesting in two equal installments on February 3, 2017 and February 3, 2018. Read SEC document |
| February 03, 2017 Filed Feb 8, 2017 23:31 UTC |
Stromatt Scott CChief Medical Officer and SVP
|
Exercise / conversionCommon Stock | 27,381 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001019056-17-000113 · stromatt_4.xml · nonDerivative · entry 1 Stromatt Scott C · CIK 0001679975 · Chief Medical Officer and SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,625 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each RSU converts into the Issuer's common stock on a one-for-one basis. Read SEC document |
| February 03, 2017 Filed Feb 8, 2017 23:28 UTC |
Lamothe Jeffrey G.SVP, CFO and Treasurer
|
Exercise / conversionRestricted Stock Unit · Derivative | 25,340 | $0.00 | $0.00 |
DisclosureSEC source: 0001019056-17-000111 · lamothe_4.xml · derivative · entry 3 Lamothe Jeffrey G. · CIK 0001679967 · SVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,654 Underlying: Common Stock · 25,340 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU converts into the Issuer's common stock on a one-for-one basis. F2 · derivative.exercise_date: On August 3, 2016, the reporting person was granted 50,680 RSUs, vesting in two equal installments on February 3, 2017 and February 3, 2018. F2 · derivative.expiration_date: On August 3, 2016, the reporting person was granted 50,680 RSUs, vesting in two equal installments on February 3, 2017 and February 3, 2018. Read SEC document |
| February 03, 2017 Filed Feb 8, 2017 23:28 UTC |
Lamothe Jeffrey G.SVP, CFO and Treasurer
|
Tax withholdingCommon Stock | 8,274 | $1.92 | $15,886.08 |
DisclosureSEC source: 0001019056-17-000111 · lamothe_4.xml · nonDerivative · entry 2 Lamothe Jeffrey G. · CIK 0001679967 · SVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,066 Read SEC document |
| February 03, 2017 Filed Feb 8, 2017 23:28 UTC |
Lamothe Jeffrey G.SVP, CFO and Treasurer
|
Exercise / conversionCommon Stock | 25,340 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001019056-17-000111 · lamothe_4.xml · nonDerivative · entry 1 Lamothe Jeffrey G. · CIK 0001679967 · SVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,340 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each RSU converts into the Issuer's common stock on a one-for-one basis. Read SEC document |
| August 03, 2016 Filed Sep 27, 2016 19:43 UTC Amendment |
Stromatt Scott CChief Medical Officer and SVP
|
GrantRestricted Stock Unit · Derivative | 78,123 | $0.00 | $0.00 |
DisclosureSEC source: 0001019056-16-001559 · stromatt_4a.xml · derivative · entry 3 Stromatt Scott C · CIK 0001679975 · Chief Medical Officer and SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,322 Underlying: Common Stock · 78,123 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents the right of the reporting person to receive one share of common stock of the Issuer. F4 · derivative.exercise_date: This report has been amended to reflect that the RSUs will vest on August 1, 2017. F4 · derivative.expiration_date: This report has been amended to reflect that the RSUs will vest on August 1, 2017. F5 · balance_after: This report has been amended to reflect the 101,437 RSUs that were originally issued by Emergent and, as a result of the spin-off of the Issuer from Emergent effective on August 1, 2016, were adjusted and assumed by the Issuer under its Converted Equity Awards Incentive Plan. Read SEC document |
| August 03, 2016 Filed Sep 27, 2016 19:43 UTC Amendment |
Stromatt Scott CChief Medical Officer and SVP
|
GrantRestricted Stock Unit · Derivative | 54,762 | $0.00 | $0.00 |
DisclosureSEC source: 0001019056-16-001559 · stromatt_4a.xml · derivative · entry 2 Stromatt Scott C · CIK 0001679975 · Chief Medical Officer and SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,762 Underlying: Common Stock · 54,762 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents the right of the reporting person to receive one share of common stock of the Issuer. F3 · derivative.exercise_date: This report has been amended to reflect that the RSUs will vest in two equal installments on February 3, 2017 and February 3, 2018. F3 · derivative.expiration_date: This report has been amended to reflect that the RSUs will vest in two equal installments on February 3, 2017 and February 3, 2018. Read SEC document |
| August 03, 2016 Filed Sep 27, 2016 19:45 UTC Amendment |
White Marvin LDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 200,475 | $0.00 Strike: $2.94 | $0.00 |
DisclosureSEC source: 0001019056-16-001561 · white_4a.xml · derivative · entry 2 White Marvin L · CIK 0001493324 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,118 Underlying: Common Stock · 200,475 shares Expires 2026-08-03 F2 · derivative.exercise_date: The stock options were granted on August 3, 2016 and vest in three equal installments on August 3, 2017, August 3, 2018 and August 3, 2019. F3 · balance_after: This report has been amended to reflect the 35,643 options that were originally issued by Emergent and, as a result of the spin-off of the Issuer from Emergent effective on August 1, 2016, were adjusted and assumed by the Issuer under its Converted Equity Awards Incentive Plan. Read SEC document |
| August 03, 2016 Filed Sep 27, 2016 19:42 UTC Amendment |
Lamothe Jeffrey G.SVP, CFO and Treasurer
|
GrantRestricted Stock Unit · Derivative | 50,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001019056-16-001557 · lamothe_4a.xml · derivative · entry 2 Lamothe Jeffrey G. · CIK 0001679967 · SVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,994 Underlying: Common Stock · 50,680 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents the right of the reporting person to receive one share of common stock of the Issuer. F3 · derivative.exercise_date: This report has been amended to reflect that the RSUs will vest in two equal installments on February 3, 2017 and February 3, 2018. F3 · derivative.expiration_date: This report has been amended to reflect that the RSUs will vest in two equal installments on February 3, 2017 and February 3, 2018. F4 · balance_after: This report has been amended to reflect the 35,451 RSUs that were originally issued by Emergent BioSolutions, Inc. ("Emergent") and, as a result of the spin-off of the Issuer from Emergent effective on August 1, 2016, were adjusted and assumed by the Issuer under its Converted Equity Awards Incentive Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.